Best of The IN VIVO Blog (02/2010)
Executive Summary
A selection of our favorite blog posts from January 2010 about stories not covered elsewhere in this issue of IN VIVO. (See the original postings for free at http://invivoblog.blogspot.com/).
You may also be interested in...
Biopharma Trends: Nowhere To Go But Up
Biopharmaceutical trends in 2008 were fundamentally altered by the global financial crisis. And 2009's events were similarly impacted by the ongoing recovery. VCs hunkered down as capital and exits remained scarce, and pharmaceutical acquirers remained cautious.Those deals that did get done were typically structured affairs or options-to-deal. In addition, health care reform added to the ongoing drama and uncertainty
Corporate Venture Capital: Will It Remain A Mainstay If The Markets Improve?
An analysis of corporate venture investment since the beginning of 2008.
Victoza Outperforms Byetta In Head-To-Head Trial
Head-to-head trial results presented at the American Diabetes Association meeting are positive, but safety questions aren't likely to go away.